U.S Physical Therapy Share Holder Equity 2010-2024 | USPH

U.S Physical Therapy share holder equity from 2010 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
U.S Physical Therapy Annual Share Holder Equity
(Millions of US $)
2023 $477
2022 $317
2021 $297
2020 $278
2019 $242
2018 $217
2017 $206
2016 $189
2015 $172
2014 $167
2013 $151
2012 $135
2011 $122
2010 $116
2009 $92
U.S Physical Therapy Quarterly Share Holder Equity
(Millions of US $)
2024-06-30 $486
2024-03-31 $481
2023-12-31 $477
2023-09-30 $494
2023-06-30 $490
2023-03-31 $319
2022-12-31 $317
2022-09-30 $319
2022-06-30 $309
2022-03-31 $302
2021-12-31 $297
2021-09-30 $291
2021-06-30 $285
2021-03-31 $277
2020-12-31 $278
2020-09-30 $266
2020-06-30 $257
2020-03-31 $242
2019-12-31 $242
2019-09-30 $237
2019-06-30 $231
2019-03-31 $221
2018-12-31 $217
2018-09-30 $213
2018-06-30 $213
2018-03-31 $208
2017-12-31 $206
2017-09-30 $200
2017-06-30 $196
2017-03-31 $193
2016-12-31 $189
2016-09-30 $219
2016-06-30 $214
2016-03-31 $209
2015-12-31 $172
2015-09-30 $186
2015-06-30 $182
2015-03-31 $176
2014-12-31 $167
2014-09-30 $163
2014-06-30 $164
2014-03-31 $154
2013-12-31 $151
2013-09-30 $147
2013-06-30 $147
2013-03-31 $140
2012-12-31 $135
2012-09-30 $136
2012-06-30 $133
2012-03-31 $126
2011-12-31 $122
2011-09-30 $122
2011-06-30 $115
2011-03-31 $113
2010-12-31 $116
2010-09-30 $107
2010-06-30 $104
2010-03-31 $99
2009-12-31 $92
2009-09-30 $92
2009-06-30 $89
2009-03-31 $88
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $1.464B $0.605B
U.S. Physical Therapy, Inc. is the largest publicly-traded, pure-play operator of outpatient physical and occupational therapy clinics. The clinics provide pre- and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, rehabilitation of injured workers and preventative care. USPh also manages several physical therapy facilities for third parties, including physician groups. Each of USPh's clinics are directed by a licensed physical therapist that drive patient volume via local physicians, former patients and other referral sources. Marketing representatives are used to further augment sales. Historically, USPh has grown its business through de novo development; approximately two-thirds of USPh clinics were originally start-ups. Strategic acquisitions, which accelerate the Company's growth, are structured like the de novo partnerships, with significant ownership retained by founders.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $20.921B 12.66
Quest Diagnostics (DGX) United States $17.320B 17.55
DaVita (DVA) United States $12.060B 15.60
Encompass Health (EHC) United States $10.267B 24.21
Chemed (CHE) United States $8.277B 25.44
Elanco Animal Health (ELAN) United States $6.357B 14.29
RadNet (RDNT) United States $5.166B 122.54
Option Care Health (OPCH) United States $3.999B 18.95
Amedisys (AMED) United States $3.199B 22.78
Astrana Health (ASTH) United States $2.920B 41.31
LifeStance Health (LFST) United States $2.728B 0.00
Addus HomeCare (ADUS) United States $2.375B 27.86
Pennant (PNTG) United States $1.004B 46.00
Aveanna Healthcare Holdings (AVAH) United States $0.929B 0.00
Atai Life Sciences (ATAI) Germany $0.198B 0.00
Daxor (DXR) United States $0.047B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.015B 0.00
Psychemedics (PMD) United States $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.013B 0.00
Ontrak (OTRK) United States $0.007B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00